Decoding anoikis-related genes in lung adenocarcinoma brainmetastasis via single-cell RNA sequencing: CD44-mediated

Zheng Tao1,2, Shuang Li2, Haifeng Xia2

  • 1Department of Thoracic Surgery, the First Affiliated Hospital of Wannan Medical College, Wannan Medical College, Wuhu, China.

BMC Cancer
|December 26, 2025
PubMed
Abstract

Insights

Anoikis-related genes (ARGs) drive lung cancer brain metastasis. CD44, an ARG, is overexpressed in brain metastases and crucial for tumor progression, offering prognostic value.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Anoikis, a programmed cell death, is linked to tumor invasion and metastasis.
  • Lung adenocarcinoma (LUAD) with brain metastasis has a poor prognosis.
  • Investigating Anoikis-related genes (ARGs) in lung cancer brain metastasis is crucial.

Purpose of the Study:

  • To explore the role of ARGs in lung cancer brain metastasis.
  • To identify molecular mechanisms driving metastasis.
  • To develop a prognostic model for lung cancer brain metastasis.

Main Methods:

  • Single-cell RNA sequencing (scRNA-seq) of lung cancer and brain metastasis samples.
  • Analysis of cell communication, transcription factor regulation, and ARG scoring.
  • Development and validation of a prognostic model using bulk RNA sequencing and clinical samples.

Main Results:

  • Epithelial cells showed significant differences between lung tumors and brain metastases.
  • VEGF signaling and distinct regulatory networks were identified.
  • A prognostic model highlighted ITGA2, ITGA3, CD44, and BIRC3; CD44 overexpression correlated with brain metastasis and functional impairment upon knockdown.

Conclusions:

  • Epithelial cells undergo significant changes during lung cancer brain metastasis.
  • ARGs, especially CD44, are critical for lung cancer brain metastasis progression.
  • CD44 holds prognostic significance for patients with lung cancer brain metastasis.